Benefit of adjuvant systemic therapies in HR+ HER2- pT1ab node-negative breast carcinomas

Authors :: Roman Rouzier
Emile Daraï
Fabien Reyal
Charles Coutant
P. Crochet
J-M Classe
A.-S. Azuar
Pierre-Emmanuel Colombo
Monique Cohen
Guillaume Blache
Chafika Mazouni
M.-P. Chauvet
G. Houvenaeghel
Richard Villet
Jean-Marie Boher
A. De Nonneville
Eric Lambaudie
A. Gonçalves
Eva Jouve
P. Gimbergues
Source :: Annals of Oncology. 29:viii63
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
business.industry
medicine.medical_treatment
Internal medicine
medicine
Hematology
business
Adjuvant
Node negative

Full Text Access

Tools